Gaul; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gaul; Christoph.The latest application filed is for "17a-hydroxylase/c17,20-lyase inhibitors".

Company Profile

1.21.23

Gaul; Christoph - Aesch N/A CH
Gaul; Christoph - Liestal CH
Gaul; Christoph - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof Grant 9,789,118 - Barnes , et al. October 17, 2	2017-10-17
17a-hydroxylase/C17,20-lyase inhibitors Grant 9,339,501 - Bock , et al. May 17, 2	2016-05-17
17a-HYDROXYLASE/C17,20-LYASE INHIBITORS App 20150209356 - Bock; Mark Gary ; et al.	2015-07-30
17.alpha.-hydroxylase/C.sub.17,20-lyase inhibitors Grant 9,029,399 - Bock , et al. May 12, 2	2015-05-12
Migrastatin analogs in the treatment of cancer Grant 8,957,056 - Danishefsky , et al. February 17, 2	2015-02-17
17.alpha.-hydroxylase/C.sub.17,20-lyase inhibitors Grant 8,946,260 - Bock , et al. February 3, 2	2015-02-03
Inhibitors of CYP 17 Grant RE45,173 - Bock , et al. September 30, 2	2014-09-30
Migrastatin analogs and uses thereof Grant 8,835,693 - Danishefsky , et al. September 16, 2	2014-09-16
17a-HYDROXYLASE/C17,20-LYASE INHIBITORS App 20140228386 - Bock; Mark Gary ; et al.	2014-08-14
Inhibitors Of Cyp 17 App 20140228394 - BOCK; Mark Gary ; et al.	2014-08-14
Bicyclic Acetyl-coa Carboxylase Inhibitors And Uses Thereof App 20140171363 - BARNES; David Weninger ; et al.	2014-06-19
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof Grant 8,697,739 - Barnes , et al. April 15, 2	2014-04-15
17a-HYDROXYLASE/C17,20-LYASE INHIBITORS App 20140045872 - Bock; Mark Gary ; et al.	2014-02-13
Migrastatin Analogs And Uses Thereof App 20140011844 - Danishefsky; Samuel J. ; et al.	2014-01-09
Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors Grant 8,420,657 - Gaul , et al. April 16, 2	2013-04-16
Migrastatin analogs and uses thereof Grant 8,324,284 - Danishefsky , et al. December 4, 2	2012-12-04
Inhibitors of CYP 17 Grant 8,263,635 - Bock , et al. September 11, 2	2012-09-11
Migrastatin analog compositions and uses thereof Grant 8,202,911 - Huang , et al. June 19, 2	2012-06-19
Organic Compounds App 20120142685 - Dobler; Markus Rolf ; et al.	2012-06-07
Quinoxaline derivatives as tyrosine kinase activity inhibitors Grant 8,193,189 - Gerspacher , et al. June 5, 2	2012-06-05
Bicyclic Acetyl-coa Carboxylase Inhibitors And Uses Thereof App 20120028969 - BARNES; David Weninger ; et al.	2012-02-02
Migrastatin Analogs And Uses Thereof App 20110281916 - Danishefsky; Samuel J. ; et al.	2011-11-17
Migrastatin Analog Compositions And Uses Thereof App 20110263653 - Huang; Xin-Yun ; et al.	2011-10-27
Migrastatin analogs and uses thereof Grant 7,943,800 - Danishefsky , et al. May 17, 2	2011-05-17
Inhibitors of CYP 17 App 20100331326 - BOCK; Mark G. ; et al.	2010-12-30
Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors App 20100168062 - Gerspacher; Marc ; et al.	2010-07-01
2, 6-naphthridine Derivatives App 20100130469 - van Eis; Maurice ; et al.	2010-05-27
Heterocyclic compounds as antiinflammatory agents App 20100041662 - Ferrand; Sandrine ; et al.	2010-02-18
Heterocyclic Compounds App 20090203688 - GAUL; Christoph ; et al.	2009-08-13
Migrastatin analogs in the treatment of cancer App 20090124662 - Danishefsky; Samuel J. ; et al.	2009-05-14
Migrastatin analogs and uses thereof App 20070037783 - Huang; Xin-Yun ; et al.	2007-02-15
Migrastatin analogs and uses thereof App 20070037852 - Danishefsky; Samuel J. ; et al.	2007-02-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.